Definitive QT Study With MT-8554
Clinical trial NCT03471130 · COMPLETED
Trial details
- NCT number
- NCT03471130
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-23
- Primary completion
- 2018-10-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.